Lilly Warns Doctons on Strattera Use
Drug maker Eli Lilly & Co. warned doctors Friday to stop using the attention deficit disorder drug Strattera in patients with jaundice or who show signs of liver problems.
Lilly placed a boldface warning on the label and in prescribing information for the drug to alert doctors after at least two patients on the medication developed liver problems. Both patients recovered normal liver function after stopping the medication, the Indianapolis-based company said.
You can skip to the end and leave a response. Pinging is currently not allowed.
Join the Conversation! Post a Comment:
Last reviewed: By John M. Grohol, Psy.D. on 20 Dec 2004






